Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

GSK (LSE: GSK) Latest News

A mature woman help a senior woman out of a car as she takes her to the shops.
Investing Articles

Down 15% and with a P/E below 9! Is the GSK share price still in deep value territory?

| Harvey Jones

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing…

Read more »

A GlaxoSmithKline scientist uses a microscope
Investing Articles

The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now?

| Mark Hartley

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set…

Read more »

Man smiling and working on laptop
Investing Articles

GSK shares leap 5% as results top forecasts and guidance is upgraded! Can they keep rising?

| Royston Wild

Strong full-year trading and an improving outlook have propelled GSK's share price higher, as Royston Wild explains.

Read more »

Two elderly people relaxing in the summer sunshine Box Hill near Dorking Surrey England
Investing Articles

Is it game over for the GSK share price?

| Harvey Jones

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Down 16% and 18% – are my 2 biggest FTSE 100 losers about to rally hard?

| Harvey Jones

Two FTSE 100 stocks in Harvey Jones' portfolio have suffered double-digit losses. He's standing by them for now, but he's…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Anywhere under £45.27, GSK’s share price looks cheap to me

| Simon Watkins

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had.…

Read more »

GSK scientist holding lab syringe
Investing Articles

Preparing for profit: 3 ways investors could thrive in a stock market crash

| Mark Hartley

The stock market can be a scary place for those who aren’t prepared. Our writer outlines three ways we might…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

2 huge investment risks I’m worried about in 2025

| Ken Hall

Ken Hall looks at two big investment risks that are keeping him up at night as we enter 2025 with…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

Looming recession? Here are 3 defensive FTSE 100 stocks to consider buying for 2025

| Paul Summers

Only a few days into 2025 and the doomsayers are out in force. Which stocks might help to cushion the…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

2 cheap shares I’ve bought to build my wealth after 50

| Harvey Jones

Harvey Jones says the FTSE 350 is packed with cheap shares right now. He's bought these two at a reduced…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

3 cheap FTSE 100 shares that could rocket in 2025!

| Harvey Jones

These three FTSE shares have taken a real beating over the last year, which is bad news for Harvey Jones…

Read more »

Passive income text with pin graph chart on business table
Dividend Shares

How to invest £20,000 in 2025 to generate safe passive income

| Edward Sheldon, CFA

It’s easy to generate passive income from the stock market today. Here’s how Edward Sheldon thinks investors should build an…

Read more »